CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 65 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,325 | -53.2% | 198,168 | -26.6% | 0.00% | – |
| Q2 2023 | $618,648 | +6410.0% | 270,152 | +2486.9% | 0.00% | – |
| Q1 2023 | $9,503 | -66.1% | 10,443 | -63.1% | 0.00% | – |
| Q2 2022 | $28,000 | -82.9% | 28,300 | -71.8% | 0.00% | – |
| Q1 2022 | $164,000 | -84.6% | 100,283 | -77.4% | 0.00% | – |
| Q4 2021 | $1,066,000 | -60.1% | 442,836 | -19.9% | 0.00% | – |
| Q3 2021 | $2,675,000 | +771.3% | 552,797 | +380.3% | 0.00% | – |
| Q2 2021 | $307,000 | -44.7% | 115,106 | -36.1% | 0.00% | – |
| Q1 2021 | $555,000 | -22.5% | 180,038 | -10.4% | 0.00% | – |
| Q4 2020 | $716,000 | +267.2% | 200,962 | +313.5% | 0.00% | – |
| Q3 2020 | $195,000 | -21.4% | 48,600 | -58.7% | 0.00% | – |
| Q1 2020 | $248,000 | -32.8% | 117,606 | +73.2% | 0.00% | – |
| Q4 2019 | $369,000 | – | 67,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,749,379 | $18,147,000 | 3.77% |
| VR Adviser, LLC | 3,427,461 | $16,589,000 | 2.13% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $15,854,000 | 2.04% |
| Telemetry Investments, L.L.C. | 196,168 | $949,000 | 1.28% |
| DC Investments Management, LLC | 50,709 | $245,000 | 0.46% |
| Orbimed Advisors | 6,943,654 | $33,607,000 | 0.37% |
| EcoR1 Capital, LLC | 2,081,077 | $10,072,000 | 0.35% |
| BVF INC/IL | 1,370,947 | $6,635,000 | 0.26% |
| Ikarian Capital, LLC | 757,545 | $3,666,000 | 0.26% |
| CHI Advisors LLC | 165,927 | $803,000 | 0.23% |